Disease Modifying Drugs > Azathioprine (Imuran)
| Dosage: | Start 25mg - 50mg twice daily orally | |
| Increase to 50mg tds if no response in 3 months |
Several important drug interactions.
Check BNF before co-prescribing.
Investigations before starting treatment performed by rheumatologist
Monitoring of treatment by primary health care team
Monitoring of Methotrexate treatment by primary health care team
| Investigation | Frequency | Action required | ||||||
| FBC | Weekly for THREE months, then Monthly |
|
||||||
| Check B12 and folate if macrocytosis
|
||||||||
| LFT | Every 2 Months | STOP if: >twofold rise in AST or ALT or Alk Phos | ||||||
| U&E | Every 4 Months |
Please note that in addition to absolute values for haematological indices
a rapid fall
or consistent downward trend in any values should prompt caution and extra
vigilance.
Side effects
| Mouth ulcers, rash | STOP |
| Nausea | Split or reduce dose - get advice if persistent |
These guidelines have been with permission from the department of rheumatology, Gwent Rheumatology Service.
| Top |